Vertex Pharmaceuticals: Clinical Trials & Research Profile

Biopharma Industry (Boston, MA) · Primary Focus: Respiratory and Pulmonary

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Boston, MA)
Primary Therapeutic AreaRespiratory and Pulmonary
Active Phase II & III Studies26 active (11 recruiting now)
Total Tracked Studies (2018 to 2026)78 (51 with California sites)
Completed vs Early-Stopped Studies48 completed / 4 stopped (5.1% stop rate)
Median Closed Enrollment87 participants
FDA Drugs@FDA Original Approvals10 all-time (6 from 2018 to 2026)
Physical Hospital Site Disclosure96.9% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Vertex Pharmaceuticals across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk